Company: MBIO
Filing Date: 2025-01-10
Form Type: PRE 14C
Source: 0001104659-25-002602
Chunk: 10

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-10
Form: PRE 14C
Chunk 10
---
, nominees, custodians, fiduciaries and other
like parties to forward this Information Statement to the beneficial owners of the common stock held of record by them and will reimburse
such persons for their reasonable charges and expenses in connection therewith. The Board has fixed the close of business on January
10, 2025 as the record date for the determination of stockholders who are entitled to receive this Information Statement.

This Information Statement is being mailed on
or about ,
2025 to all stockholders of record as of the Record Date.

<div align='center'>CONCLUSION</div>

As a matter of regulatory
compliance, we are sending you this Information Statement that describes the purpose and effect of the above actions. Your consent to
the above action is not required and is not being solicited in connection with this action. This Information Statement is intended to
provide our stockholders information required by the rules and regulations of the Exchange Act.

| BY ORDER OF THE BOARD OF DIRECTORS |     |                                                                        |
| ,                                  
 2025                               | By: |                                                                        |
|                                    |     | Manuel Litchman, M.D.                                                  |
|                                    |     | President, Chief Executive Officer and Interim Chief Financial Officer |